Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Frytak

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
American Journal of Clinical Oncology|August 1, 1994
Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant diseaseT G Call, E T Creagan, S Frytak, et al.
Cancer Treatment Reports|May 1, 1976
Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancerD L Ahmann, H F Bisel, R T Eagan, et al.
American Journal of Clinical Oncology|January 22, 2002
Long-term results of a phase I/II study of high-dose thoracic radiotherapy with concomitant cisplatin and etoposide in limited stage small-cell lung cancerP D Brown, J A Bonner, R L Foote, et al.
Cancer Treatment Reports|March 1, 1981
Phase II evaluation of PALA in patients with metastatic lung cancerE T Creagan, R T Eagan, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|July 1, 1981
Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Cancer Treatment Reports|April 1, 1980
Phase II study of maytansine and chlorozotocin in patients with disseminated malignant melanomaD L Ahmann, S Frytak, L K Kvols, et al.
American Journal of Clinical Oncology|February 1, 1987
Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary reportS Frytak, R T Eagan, R L Richardson, et al.
Cancer Treatment Reports|December 1, 1977
Phase II study of cytosine arabinoside in advanced large bowel cancerS A Cullinan, M J O'Connell, C G Moertel, et al.
Cancer Treatment Reports|October 1, 1977
Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancerR T Eagan, J N Ingle, S Frytak, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
American Journal of Clinical Oncology|August 1, 1994
Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant diseaseT G Call, E T Creagan, S Frytak, et al.
Cancer Treatment Reports|May 1, 1976
Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancerD L Ahmann, H F Bisel, R T Eagan, et al.
American Journal of Clinical Oncology|January 22, 2002
Long-term results of a phase I/II study of high-dose thoracic radiotherapy with concomitant cisplatin and etoposide in limited stage small-cell lung cancerP D Brown, J A Bonner, R L Foote, et al.
Cancer Treatment Reports|March 1, 1981
Phase II evaluation of PALA in patients with metastatic lung cancerE T Creagan, R T Eagan, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|July 1, 1981
Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Cancer Treatment Reports|April 1, 1980
Phase II study of maytansine and chlorozotocin in patients with disseminated malignant melanomaD L Ahmann, S Frytak, L K Kvols, et al.
American Journal of Clinical Oncology|February 1, 1987
Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary reportS Frytak, R T Eagan, R L Richardson, et al.
Cancer Treatment Reports|December 1, 1977
Phase II study of cytosine arabinoside in advanced large bowel cancerS A Cullinan, M J O'Connell, C G Moertel, et al.
Cancer Treatment Reports|October 1, 1977
Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancerR T Eagan, J N Ingle, S Frytak, et al.
Pageof 11